AGTX on OTC
Agentix Corp.
$0.02 up 0.00 (0.00%)Price as of Oct 15, 2026 at 14:59 UTC
Last updated Oct 18, 2026.
Overview
-$485.6KNet income, fiscal 20263
Compare with CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC., Allogene Therapeutics, Inc. or Senti Biosciences Holdings, Inc., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
-100.0%Revenue growth, 20235
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2026-03-31 | 2025-03-31 |
|---|---|---|
| Professional fees | $252.0K | $262.4K |
| Research and development | $125.1K | $181.0K |
| General and administrative expenses | $68.1K | $69.9K |
| Total operating expenses | $445.2K | $513.3K |
| Loss from operations | -$445.2K | -$513.3K |
| Foreign exchange gain (loss) | -$24.6K | $11.1K |
| Interest expense, net | $80.1K | $42.7K |
| Interest income | $0 | $0 |
| Other income | -$15.1K | $0 |
| Other loss (income), net | $40.4K | $53.8K |
| Loss before income tax provision | -$485.6K | -$567.0K |
| Income tax provision | $0 | $0 |
| Net loss | -$485.6K | -$567.0K |
| Change in foreign currency translation, net of tax | $9.0K | -$23.0K |
| Total comprehensive loss | -$476.6K | -$602.2K |
| - Basic and diluted | -$0.01 | -$0.01 |
| - Basic and diluted | 40.1M shares | 40.1M shares |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2026-03-31 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|
| Cash | $771 | $4.5K | $6.5K |
| Prepaid expense and other current assets | $0 | $95.8K | |
| Total current assets | $771 | $100.3K | |
| Total assets | $771 | $100.3K | |
| Accounts payable | $715.9K | $968.9K | |
| Accounts payable - related parties | $2.4M | $1.9M | |
| Note payable - related party | $353.4K | $243.0K | |
| Accrued expenses | $143.9K | $60.2K | |
| Total current liabilities | $3.6M | $3.2M | |
| Long Term Liabilities | $0 | $0 | |
| Total liabilities | $3.6M | $3.2M | |
| Commitments and Contingencies | $0 | $0 | |
| Common stock par value $0.001: 50,000,000 shares authorized; 40,066,951 shares issued and outstanding as of March 31, 2026 and March 31, 2025, respectively | $40.1K | $40.1K | |
| Common stock to be issued (357,102 at March 31, 2026 and March 31, 2025, respectively) | $53.5K | $53.5K | |
| Additional paid-in capital | $3.3M | $3.3M | |
| Accumulated other comprehensive income | $29.8K | $35.4K | |
| Accumulated deficit | -$7.0M | -$6.5M | |
| Total stockholders' deficit | -$3.6M | -$3.1M | -$2.6M |
| Total liabilities and stockholders' deficit | $771 | $100.3K | |
| Common stock, shares par value | $0.00 | $0.00 | |
| Common stock, shares authorized | 50.0M shares | 50.0M shares | |
| Common stock, shares issued | 40.1M shares | 40.1M shares | |
| Common stock, shares outstanding | 40.1M shares | 40.1M shares | |
| Common stock to be issued | 357.1K shares | 357.1K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2026-03-31 | 2025-03-31 |
|---|---|---|
| Net loss | -$485.6K | -$567.0K |
| Gain on settlement of payables | -$20.6K | $0 |
| Prepayments and other current assets | $95.8K | $4.0K |
| Accrued expenses, accounts payable and accounts payable-related party | $301.9K | $437.9K |
| Net Cash Provided by (Used in) Operating Activities | -$108.5K | -$125.1K |
| Cash Flows from Investing Activities | $0 | $0 |
| Proceeds from issuance of debt | $110.5K | $100.0K |
| Net Cash Provided by Financing Activities | $110.5K | $100.0K |
| Effects of Foreign Exchange Rate Changes on Cash | -$5.6K | $23.0K |
| Net Change in Cash | -$3.7K | -$2.1K |
| Interest paid | $0 | $0 |
| Income tax paid | $0 | $0 |
Former names
- FairWind Energy Inc.Apr 1, 2014 to Jun 27, 20194
Recent filings
- Aug 10, 202610-Q
- Jul 1, 202610-K
- Feb 17, 202610-Q
- Nov 20, 202510-Q
- Aug 22, 202510-Q
- Aug 15, 2025NT 10-Q
- Jul 16, 202510-K
- Jul 1, 2025NT 10-K
- Feb 18, 202510-Q
- Feb 14, 2025NT 10-Q
- Nov 18, 202410-Q
- Nov 14, 2024NT 10-Q
- Sep 25, 202410-Q
- Aug 30, 202410-K
- Aug 15, 2024NT 10-Q
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAgentix Corp. filings on SEC EDGAR
- 2Yahoo FinanceAGTX quote
- 3SEC EDGARAgentix Corp. 10-K for fiscal 2026
- 4SEC EDGARAgentix Corp. filings on SEC EDGAR
- 5SEC EDGARAgentix Corp. 10-K for fiscal 2023
- 6SEC EDGARAgentix Corp. 10-K for fiscal 2021
- 7SEC EDGARAgentix Corp. 10-K for fiscal 2019
- 8SEC EDGARAgentix Corp. 10-K for fiscal 2023
- 9SEC EDGARAgentix Corp. 10-Q for fiscal 2025
- 10SEC EDGARAgentix Corp. 10-Q for fiscal 2025
- 11SEC EDGARAgentix Corp. 10-Q for fiscal 2026
- 12SEC EDGARAgentix Corp. 10-K for fiscal 2023